Synthesis of 5-3-bromo phenyl and 5-3 choloro phenyl- 1,3,4 oxadiazol-2 eyl piridin-2-eyl methanol and evaluation of antibacterial activity

Document Type : Original article

Authors

1 MSc student in Microbiology ,Department of Microbiology, Faculty of Basic Science, Shahrekord Branch, Islamic Azad University, Iran

2 Associate Professor of Microbiology ,Department of Microbiology, Faculty of Basic Sience, Islamic Azad University, Shahrekord Branch, Iran.

3 1. Department of Microbiology, Faculty of Basic Science, Shahrekord Branch, Islamic Azad University, Iran. 2. Associate Professor, Faculty of Science, Urmia Branch, Islamic Azad University, Iran

Abstract

Introduction: Oxadiazole derivatives that are highly bioavailable, for example, can be a good alternative to antimicrobials and may have a better effect on the same drugs than those of the host. The aim of this study was to evaluate the antibacterial properties of oxadiazole synthesized derivatives and compare it with common antibacterial drugs on some pathogenic bacteria.
Material and Methods: In this study in a single process reaction of N- isocyanimino triphenyiphosphorane, carboxylic acid derivatives and 2-pyridinecarbalhyde in acetonitrile solvent, new derivatives of Oxadiazole were attained. The structures of synthesis compounds were surveyed and established by the use of IR, H-NMR and C-NMR spectrometer. The synthesized compounds were tested for their antimicrobial activity against Entrococcus faecalis PTCC 1788 and Proteus vulgaris PTCC 1861 by disc diffusion method and Minimal Inhibitory Concentration (MIC) and determination of Minimal Bactericidal Concentration (MBC).
Results: The results that show all the synthesized compounds had antibacterial activity against E. faecalis, but they did not have that much influence on P. vulgaris.
Discussion: This is important that the synthesis of oxadiazole compounds has antibacterial nature which is a single-process reaction and it was accomplished with high efficiency and in a very short time.

Keywords

References

1.Mahon CR, Manoselis G. Textbook of diagnostic microbiology. 2ⁿᵈ ed. New York: WB. Saunders Company; 2015. P. 15-158.
2. Rappé MS, Giovannoni SJ. The uncultured microbial majority. Ann Rev Microbiol. 2017; 57(3):369-94.
3. Liss RH, Batchelor FR. Economic evaluations of antibiotic use and resistance-a perspective: report Task Force 6. Rev Infect Dis. 1987; 9(3):S297-312.
4. Chawla R, Arora A, Parameswaran MK, Chan P, Sharma D, Michael S, et al. Synthesis of novel 1,3,4- oxadiazole derivatives as potential antimicrobial agents. Acta Pol Pharm. 2010; 67(3):247-53.
5. Adelstein GW, Yen CH, Dajani EZ, Bianchi RG. 3, 3- Diphenyl-3-(2-alkyl-1, 3, 4-oxadiazol-5-yl) propylcy cloalkylamines, a novel series of antidiarrheal agents. J Med Chem. 1976; 19(10):1221-5.
6. Sangshetti JN, Chabukswar AR, Shinde DB. Microwave assisted one pot synthesis of some novel 2,5-disubstituted 1,3,4-oxadiazoles as antifungal agents. Bioorg Mad Chem Lett. 2011; 21(1):444-8.
7. Othman AA, Kihel K, Amara S. 1,3,4-oxadiazole, 1,3,4-thiadiazole and 1,2,4-triazole derivatives as potential antibacterial agents. Arabian J Chem. 2014; 23:1878.
8. Morjan RY, Mkadmh AM, Beadham I, Elmanama AA, Mattar MR, Raftery J, et al. Antibacterial activity of novel nicotinic acid hydrazides and their conversion into N-acetyl-1,3,4-oxadiazoles. Bioorg Med Chem Lett. 2014; 24(24):5796-800.
9. Ravindra KC, Vagdevi HM, Vaidya VP, Padmashali B. Synthesis, anti-microbial and anti-inflammatory activities of 1,3,4-oxadiazoles linked to naphtho [2,1- b] furan. Indian J Heterocyc. Chemist. 2006; 45(4): 2506-11.
10. Nailesh J, Korgaokar S, Parekh H. Synthesis and antimicrobial activity of substituted 1,3,4-oxadiazoles. Indian J Heterocyc Chem. 1996; 5(3):241-2.
11. Rai NP, Narayanaswamy VK, Shashikanth S, Arunachalam PN. Synthesis characterization and antibacterial activity of 2-[1 (5-chloro-2-methoxyphenyl)-5-methyl-1H-pyrazol-4-yl]-5. substitutedphenyl)-[1,3,4] oxadiasoles. Eur J Med Chem. 2009;
44(3):4522-7.
12. Hedrick JL, Twieg R. Poly (aryl ether oxadiazoles). Macromolecules. 1992; 25(7):2021-5.
13. Ciccarelli FD, Doerks T, von Mering C, Creevey CJ, Snel B, Bork P. Toward automatic reconstruction of a highly resolved tree of life. Science. 2006; 56(6):1283-7.
14. Gurupadaswamy HD, Girish V, Kavitha CV, Raghavan SC, Khanum SA. Synthesis and evaluation of 2,5-di(4-aryloylaryloxymethyl)-1,3,4-oxadiazoles as anti-cancer agents. Eur J Med Chem. 2013; 63: 536-43.
15. Gupta K. Addressing antibiotic resistance. Dis Mon.2003; 49(2):99-110.
16. Liss RH, Batchelor FR. Economic evaluations of antibiotic use and resistance-a perspective: report. Rev Infect Dis. 1987; 9(3):297-312.
17. Souldozi A, Shojaei SH, Ramazani A, Slepokurad K, Lisd T. Synthesis and crystal structure of N-(2-(1,3,4- oxadiazol-2-yl) phenyl)-2,3-dimethylaniline. Chinese J Struct Chem Rep. 2014; 5(2):407-14.
18. Kitao T, Tada T, Tanaka M, Narahara K, Shimojima M, Shimada K, et al. Emergence of a novel multidrugresistant Pseudomonas aeruginosa strain producing IMP-type metallo-β-lactamases and AAC (6')-Iae in Japan. Int J Antimicrob Agents. 2012; 39(6):518-21.
19. Yousaf M, Zahoor AF, Faiz S, Javed S, Irfan M. Recent synthetic approaches towards biologically potent derivatives/analogues of theophylline. J Heterocyc Chem. 2018; 21(3):842-51.
20. Shridhar AH, Keshavayya J, Hoskeri J. Synthesis, characterization and pharmacological studies of novel bis-1,3,4-oxadiazole and 1,2,4-triazole derivatives. Der Chem Sinica. 2011; 2(4):106-14.
21. Mahajan P, Nikam M, Chate A, Nimbalkar U, Patil V, Bobade A, et al. Synthesis, antioxidant, antiinflammatory, and antimicrobial screening of newer thiophene-fused arylpyrazolyl 1,3,4-oxadiazoles. Phosph Sulfur Silicon Relat Elements. 2015;
190(11):256-65.
22. Khalilullah H, Ahsan MJ, Hedaitullah M, Khan S, Ahmed B. 1,3,4-oxadiazole: a biologically active scaffold. Mini Rev Med Chem. 2012; 12(8):789-801.
23. Lhermie G, Gröhn YT, Raboisson D. Addressing antimicrobial resistance: an overview of priority actions to prevent suboptimal antimicrobial use in food-animal production. Frontiers Microbiol. 2017; 7:2114.
24. Hou L, Shi Y, Zhai P, Le G. Antibacterial activity and in vitro anti-tumor activity of the extract of the larvae of the housefly (Musca domestica). J Ethnopharmacol. 2007; 111(2):227-31.
25. Amoo S, Ndhlala AR, Finnie JF, Van Staden J. Antibacterial, antifungal and anti-inflammatory properties of Burchellia bubaline. South Afr J Botany. 2009; 75(4):60-3.                                                                                                                               26. Alipour E, Mousavi Z, Safaei Z, Pordeli M, Safavi M, Firoozpour L, et al. Synthesis and cytotoxic evaluation of some new [1,3]dioxolo[4,5-g]chromen-8-one derivatives. Daru. 2014; 22:41.
27. Mobasheri H, Mahdiuni H, Shafiee A, Foroumadi A. Effects of novel antituberculosis agents on OmpF channel activity. Biochem Biophys Res Commun. 2008; 376(1):174-9.
28. Sonar VN, Yadav LD, Sandhya S. New Mannich bases from oxadiazolyl indoles and their antibacterial activities. Indian J Heterocyc Chem. 1995; 4:203-5.
29. Mogilaiah K, Prashanthi M. Convenient synthesis of 5-aryl-2- [p-(1, 8-naphthyridin-2yl) phenoxymethyl]- 1,3,4-oxadiazoles under microwave irradiation. Indian J Heterocyc Chem. 2000; 14(3):185-8.
30. Maslat AO, Abussaud M, Tashtoush H, Al-Talib M. Synthesis, antibacterial, antifungal and genotoxic activity of bis-1,3,4-oxadiazole derivatives. Pol J Pharmacol. 2002; 54(1):55-9.
31. Mayekar AN, Yathirajan HS, Narayana B, Sarojini BK, Kumari NS. Synthesis and antimicrobial studies on new substituted 1,3,4‐oxadiazole derivatives bearing 6‐bromonaphthalene moiety. Int J Chem. 2010; 2(1):38-54.
32. Prakash O, Kumar M, Kumar R, Sharma C, Aneja KR. Hypervalent iodine (III) mediated synthesis of novel unsymmetrical 2,5-disubstituted 1,3,4-oxadiazoles as antibacterial and antifungal agents. Eur J Med Chem. 2010; 45(9):4252-7.
33. Bhardwaj N, Saraf SK, Sharma P, Kumar P. Syntheses, evaluation and characterization of some 1, 3, 4-oxadiazoles as antimicrobial agents. J Chem. 2009; 6(4):1133-8.
34. Husain A, Ajmal M. Synthesis of novel 1, 3, 4- oxadiazole derivatives and their biological properties. Acta Pharm. 2009; 59(2):223-33.
Navid No
Volume 21, Issue 67
December 2018
Pages 53-65

Files

Share

How to cite

Statistics